跳至主要内容
临床试验/NCT01207999
NCT01207999已完成不适用

Human Papillomavirus (HPV) Type Distribution in Adult African Women Diagnosed With Invasive Cervical Cancer

GlaxoSmithKline1 个研究点 分布在 1 个国家目标入组 591 人开始时间: 2007年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
591
试验地点
1
主要终点
Occurrence of any of the human papillomavirus types (HPV-16, 18, 31, 33, 35, 45, 52 and 58) among the women diagnosed with invasive cervical cancer

研究概览

简要总结

The aim of the study is to assess the distribution of the most frequent types of human papillomavirus in African women diagnosed with invasive cervical cancer.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • A female aged 21 years or more, presenting with a lesion macroscopically suggestive of invasive cervical cancer.
  • Scheduled for cervical biopsy as per routine procedure at the participating institution on the day of the visit or on a later date.
  • Written or oral-witnessed informed consent obtained from the subject prior to any study procedure.
  • No prior chemo- or radiotherapy for cervical cancer.

排除标准

  • Not applicable

结局指标

主要结局

Occurrence of any of the human papillomavirus types (HPV-16, 18, 31, 33, 35, 45, 52 and 58) among the women diagnosed with invasive cervical cancer

时间窗: Average time frame: 6-12 months

Occurrence of any of the human papillomavirus types (human papillomavirus-16, 18, 31, 33, 35, 45, 52 and 58) among the women diagnosed with squamous cell carcinoma

时间窗: Average time frame: 6-12 months

次要结局

  • Proportion of squamous cell carcinoma cases versus adenocarcinoma and other histologic tumour types of invasive cancer among the women diagnosed with invasive cervical cancer(Average time frame:6-12 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Type Distribution of Human Papillomavirus in Adult... | 临床试验